Modulation of Anxiety-Like Behavior in Sildenafil CitrateTreated Mice Placed in an Elevated Plus-Maze

被引:0
|
作者
Shahidi, Siamak [1 ]
Hashemi-Firouzi, Nasrin [2 ]
Mahmoodi, Minoo [2 ]
机构
[1] Hamadan Univ Med Sci, Dept Physiol, Hamadan, Iran
[2] Islamic Azad Univ, Dept Biol, Hamadan Branch, Hamadan, Iran
关键词
Anxiety; Sildenafil; Acute; Elevated Plus-Maze; Mice;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: Sildenafil, a phosphodiesterase-5 (PDE5) inhibitor, may have various effects on the central nervous system via the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) pathway. Preclinical studies have shown the controversial effect of sildenafil on anxiety-like behavior in animals. This study was undertaken to investigate the acute effect of sildenafil on anxiety-like behavior in mice. Methods: Male mice were intraperitoneally (i.p.) administrated sildenafil (1, 2, or 10 mg/kg), and the control group was given the vehicle 15 min before the plus-maze test. The number of entries into the open arms of the plus-maze, the time spent in the open arms, and the total numbers of entries into the arms were recorded. Results: The results indicated that compared to the control group, the sildenafiltreated mice spent more time in the open arms and had a greater number of entries into open arms. The total number of entries into the arms did not significantly differ between the sildenafil-treated groups and the control group. Discussion: Acute administration of sildenafil could have anxiolytic effects on male mice. This effect might be mediated in a time-dependent manner by the NO/cGMP/PDE5 pathway.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 50 条
  • [1] Anxiety-like behavior in elevated plus-maze tests in repeatedly cold-stressed mice
    Hata, T
    Nishikawa, H
    Itoh, E
    Funakami, Y
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 2001, 85 (02): : 189 - 196
  • [2] Assessment of amphetamine withdrawal anxiety-like behavior in the elevated plus-maze test in rats
    Koltunowska, Dorota
    Gibula-Bruzda, Ewa
    Kotlinska, Jolanta H.
    [J]. PHARMACOLOGICAL REPORTS, 2011, 63 (02) : 560 - 561
  • [3] Assessment of amphetamine withdrawal anxiety-like behavior in the elevated plus-maze test in rats
    Dorota Kołtunowska
    Ewa Gibuła-Bruzda
    Jolanta H. Kotlińska
    [J]. Pharmacological Reports, 2011, 63 (2) : 560 - 561
  • [4] Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on
    Carobrez, AP
    Bertoglio, LJ
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2005, 29 (08): : 1193 - 1205
  • [5] Oxycodone decreases anxiety-like behavior in the elevated plus-maze test in male and female rats
    Bruijnzeel, Adriaan W.
    Behnood-Rod, Azin
    Malphurs, Wendi
    Chellian, Ranjithkumar
    Caudle, Robert M.
    Febo, Marcelo
    Setlow, Barry
    Neubert, John K.
    [J]. BEHAVIOURAL PHARMACOLOGY, 2022, 33 (06): : 418 - 426
  • [6] Effect of sildenafil on anxiety in the plus-maze test in mice
    Kurt, M
    Bilge, SS
    Aksoz, E
    Kukula, O
    Celik, S
    Kesim, Y
    [J]. POLISH JOURNAL OF PHARMACOLOGY, 2004, 56 (03): : 353 - 357
  • [7] Insular muscarinic signaling regulates anxiety-like behaviors in rats on the elevated plus-maze
    Li, Hui
    Chen, Lei
    Li, Peng
    Wang, Xiaohong
    Zhai, Haifeng
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2014, 270 : 256 - 260
  • [8] Comparative analysis of anxiety-like behavior in partition and plus-maze tests after agonistic interactions in mice
    Avgustinovich, DF
    Gorbach, OV
    Kudryavtseva, NN
    [J]. PHYSIOLOGY & BEHAVIOR, 1997, 61 (01) : 37 - 43
  • [9] Ethological confirmatory factor analysis of anxiety-like behaviour in the murine elevated plus-maze
    Wall, PM
    Messier, C
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2000, 114 (1-2) : 199 - 212
  • [10] Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior
    Wall, PM
    Messier, C
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2001, 25 (03): : 275 - 286